Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Biotech Movers: TESARO Inc (NASDAQ:TSRO) and Mylan N.V. (NASDAQ:MYL)

- July 14, 2017

Celgene Corporation (NASDAQ:CELG) Exercises Ex-US Rights To Abide Therapeutics, Inc. ABX-1431

Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (NASDAQ:PTCT), Puma Biotechnology Inc (NYSE:PBYI) and Nektar Therapeutics (NASDAQ:NKTR)

Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (NASDAQ:BLRX) and AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

Voyager

Biotech Movers: Sanofi SA (ADR) (NYSE:SNY) And Voyager Therapeutics, Inc. (NASDAQ:VYGR)

CVS Health Corp (NYSE:CVS) Creates New Position Of Head Of External...

Andy Parker - April 7, 2017 0
biotech report

Weekly Biotech Report Covering Epizyme Inc (NASDAQ:EPZM) Tazemetostat & Teva Pharamceutical...

David Rich - June 20, 2016 0

Esperion Therapeutics Inc (NASDAQ:ESPR): Get It While It’s Cheap

- March 20, 2017 0
merck-co-inc

Merck & Co., Inc (NYSE:MRK) Gets Coveted Approval For Keytruda

- December 2, 2016 0

Novartis AG (NYSE:NVS) Greater Use Of Technology In Transforming Medical Education

Andy Parker - February 14, 2017 0
Gilead Sciences, In

Losses And Gains For Gilead Sciences, Inc. (NASDAQ:GILD) Under President Trump...

Andy Parker - January 23, 2017 0
GlaxoSmithKline Plc

GlaxoSmithKline plc’s (ADR) (NYSE:GSK) Opens Its First Fully Dedicated Vaccines R&D...

Andy Parker - December 15, 2016 0
Flex

Cynapsus Therapeutics Inc (NASDAQ:CYNA) set for a Game Changing Topline Release

- March 10, 2016 0
vertex

Vertex Eyes a Half Billion Dollar Boost with Upcoming sNDA Decision

Jennifer Aldershot - January 15, 2016 0

Bellicum Pharmaceuticals: Here’s What Just Happened And Why it Matters

ME Staff - April 12, 2018 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 18, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 4, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019